Ensysce Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ensysce Biosciences, Inc. on March 23, 2026, covering an event that occurred on March 18, 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "ENSC."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
On March 18, 2026, the Company filed a Certificate of Correction with the State of Delaware regarding its Certificate of Designation of Series B Preferred Stock. This action was taken to correct a scrivener's error within the Company's Certificate of Incorporation. The full text of the correction is attached as Exhibit 3.1.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the administrative correction noted above.
Key Facts for Investor Verification
- Verify the specific nature of the scrivener's error corrected in the Certificate of Designation of Series B Preferred Stock by reviewing Exhibit 3.1.
- Confirm that the correction does not alter the rights, preferences, or privileges of the Series B Preferred Stock holders.
- Note that this filing is purely administrative and contains no new financial data or operational updates.